Author

Juan Guido Chiabrando

Interventional Cardiologist at Hospital Italiano de Buenos Aires - Cited by 681 - cardiology endovascular therapy evidence based medicine meta-analysis

Biography

Dr. Juan Guido Chiabrando is Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, located in Argentina. His study Coronary Bifurcations Techniques: Tackling the Interventional Cardiology Frontiers. He published 41 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with …
GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, JM Canada, ...Journal of Cardiovascular Pharmacology 77 (1), 49, 2021202
51
2021
Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials
M Lombardi, S Carbone, MG Del Buono, JG Chiabrando, GM Vescovo, ...European Heart Journal—Cardiovascular Pharmacotherapy 7 (4), e69, 2021202
29
2021
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials
A Abbate, GF Wohlford, MG Del Buono, JG Chiabrando, R Markley, ...European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 503-510, 2022202
26
2022
Clinical presentation and outcomes of acute pericarditis in a large urban hospital in the United States of America
A Vecchié, JG Chiabrando, MS Dell, A Bonaventura, AG Mauro, ...Chest 158 (6), 56-67, 2020202
25
2020
Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis
M Camilli, M Lombardi, MG Del Buono, JG Chiabrando, R Vergallo, ...European Heart Journal-Cardiovascular Pharmacotherapy 7 (3), e21-e25, 212
20
2021
Stenting techniques for coronary bifurcation lesions: Evidence from a network meta‐analysis of randomized clinical trials
JG Chiabrando, M Lombardi, GM Vescovo, GF Wohlford, RA Koenig, ...Catheterization and Cardiovascular Interventions 97 (3), E306-E318, 2021202
12
2021
Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement
FJ Romeo, JG Chiabrando, IM Seropian, JV Raleigh, HM de Chazal, ...Catheterization and Cardiovascular Interventions 98 (6), E889-E896, 2021202
12
2021
Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction
HE Billingsley, MG Del Buono, JM Canada, Y Kim, JI Damonte, ...Circulation: Heart Failure 15 (10), e00518, 2022202
9
2022
A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers
GF Wohlford, LF Buckley, D Kadariya, T Park, JG Chiabrando, S Carbone, ...PloS one 16 (5), e0247357, 2021202
9
2021
Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis
M Camilli, M Lombardi, JG Chiabrando, MG Del Buono, RA Montone, ...European Heart Journal-Cardiovascular Pharmacotherapy 7 (4), e74-e76, 2021202
8
2021
Novel common femoral artery lesion classification in patients undergoing endovascular revascularization
M Rabellino, J Valle Raleigh, JG Chiabrando, V Di Caro, J Chas, ...CardioVascular and Interventional Radiology 45 (4), 438-447, 2022202
6
2022
Effect of IL-1 blockade with anakinra on heart failure outcomes in patients with anterior versus nonanterior ST elevation myocardial infarction
MG Del Buono, JI Damonte, JG Chiabrando, R Markley, J Turlington, ...Journal of Cardiovascular Pharmacology 79 (), 774-780, 2022202
6
2022
Sodium–Glucose Cotransporter Inhibitors Reduce Mortality and Morbidity in Patients With Heart Failure: Evidence From a Meta-Analysis of Randomized Trials
M Camilli, M Lombardi, JG Chiabrando, A Zito, MG Del Buono, R Vergallo, ...American Journal of Therapeutics 29 (2), e199-e20, 2022202
4
2022
Prevalencia, predictores e impacto clínico de la rehospitalización en pacientes con estenosis valvular aórtica valorados por un Heart Team
CM GARMENDIA, IM SEROPIAN, JG CHIABRANDO, ...Revista argentina de cardiología 89 (6), 501-506, 2021202
3
2021
Pericarditis recurrence after initial uncomplicated clinical course
MG Del Buono, A Vecchié, JI Damonte, JG Chiabrando, MS Dell, ...The American journal of cardiology 160, 112-116, 2021202
3
2021
La paradoja de la obesidad en la insuficiencia cardíaca en ancianos
A Favini, C BELZITI, F Garagoli, JG CHIABRANDO, L Barbagelata, ...Revista argentina de cardiología 89 (), 211-216, 2021202
3
2021
Comparison of different stenting techniques in left main bifurcation disease: evidence from a network meta-analysis
GM Vescovo, JG Chiabrando, MD Carlo Zivelonghi, FJ Romeo, ...Journal of Invasive Cardiology 4 (4), 2022202
3
2022
Prognosis of patients with acute pulmonary embolism and discordant right ventricle strain serum biomarkers
IM Seropian, JG Chiabrando, JI Damonte, AL Halsband, MF Duckwen, ...International Journal of Cardiology 340, 88-93, 010
2
2021
The Effect of Colchicine on Mortality, Mechanical Ventilation, and Length of Stay in Patients With COVID-19 Infection: An Updated Systematic Review and Meta-analysis of …
FJ Romeo, L Barbagelata, JG Chiabrando, JI Damonte, E Moras, ...American Journal of Therapeutics 9 (3), e344-e350, 0
2
2022
Additive prognostic value of carbohydrate antigen‐125 over frailty in patients undergoing transcatheter aortic valve replacement
Additive prognostic value of carbohydrate antigen‐15 over frailty in patients undergoing transcatheter aortic valve replacementFJ Romeo, IM Seropian, JG Chiabrando, JV Raleigh, M Smietniansky, ...Catheterization and Cardiovascular Interventions 97 (), E63-E73, 010
2
2021